Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma

PHASE3TerminatedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 31, 2004

Conditions
Multiple Myeloma
Interventions
DRUG

STR(TM) (Skeletal Targeted Radiotherapy, Holmium-166-DOTMP)

Trial Locations (21)

10467

Montefiore Medical Center, The Bronx

19104

University of Pennsylvania, Philadelphia

23298

Virginia Commonwealth University, Richmond

27710

Duke University Medical Center, Durham

30322

Winship Cancer Institute of Emory University, Atlanta

33136

University of Miami, Miami

35249

University of Alabama, Birmingham

37232

Vanderbilt University Medical Center, Nashville

44106

Case Western Reserve University, Cleveland

45409

Miami Valley Hospital, Dayton

48201

Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit

52242

University of Iowa Hospital and Clinics, Iowa City

53208

Medical College of Wisconsin, Milwaukee

66160

University of Kansas Medical Center, Kansas City

68198

University of Nebraska Medical Center, Omaha

75246

Baylor University Medical Center, Dallas

77030

MD Anderson Cancer Center, Houston

80218

Rocky Mountain Cancer Centers, Denver

92868

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

98109

Fred Hutchinson Cancer Research Center, Seattle

M5G 2M9

Princess Margaret Hospital, Toronto

Sponsors
All Listed Sponsors
lead

Poniard Pharmaceuticals

INDUSTRY